Association of anxiety and depression with outcomes for kidney cancer patients undergoing nephrectomy
A recent retrospective study of 1990 adults who had a [...]
The effect of weight change on kidney cancer patients treated with targeted therapy
A recent retrospective study of 3311 patients with metastatic renal [...]
New first-line immunotherapy plus TKI combinations for metastatic kidney cancer
Approval of axitinib plus pembrolizumab and axitinib plus avelumab in [...]
Prognostic implications of aquaporin 9 expression in kidney cancer
Water channel proteins, or aquaporins (AQPs) have been found in [...]
Small primary tumour size and prognosis
A recent study published in European Urology Oncology this month [...]
Real world use of targeted therapies in war veterans with kidney cancer
A retrospective study of the use of targeted therapies for [...]
Real world use of pazopanib after immunotherapy for advanced kidney cancer
A study published in Clinical Genitourinary Cancer last month describes [...]
Avelumab as a first- or second-line treatment for metastatic kidney cancer
A recent study looked at the efficacy and safety of [...]
Comparison of first-line immunotherapy combinations for advanced kidney cancer
In this paper, three clinical trials with immunotherapy combinations for [...]
Lenvatinib plus pembrolizumab combination shows promise in metastatic kidney cancer
Interim results from an ongoing clinical trial of lenvatinib and [...]
